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Abstract
Myelin formation and maintenance are crucial for the proper function of the CNS and are orchestrated by a plethora of
factors including growth factors, extracellular matrix components, metalloproteases and protease inhibitors. Hemopexin
(Hx) is a plasma protein with high heme binding affinity, which is also locally produced in the CNS by ependymal cells,
neurons and glial cells. We have recently reported that oligodendrocytes (OLs) are the type of cells in the brain that are most
susceptible to lack of Hx, as the number of iron-overloaded OLs increases in Hx-null brain, leading to oxidative tissue
damage. In the current study, we found that the expression of the Myelin Basic Protein along with the density of myelinated
fibers in the basal ganglia and in the motor and somatosensory cortex of Hx-null mice were strongly reduced starting at 2
months and progressively decreased with age. Myelin abnormalities were confirmed by electron microscopy and, at the
functional level, resulted in the inability of Hx-null mice to perform efficiently on the Rotarod. It is likely that the poor
myelination in the brain of Hx-null mice was a consequence of defective maturation of OLs as we demonstrated that the
number of mature OLs was significantly reduced in mutant mice whereas that of precursor cells was normal. Finally, in vitro
experiments showed that Hx promotes OL differentiation. Thus, Hx may be considered a novel OL differentiation factor and
the modulation of its expression in CNS may be an important factor in the pathogenesis of human neurodegenerative
disorders.
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Introduction
Myelin formation in the brain occurs predominantly postnatally
in well-regulated steps during which oligodendrocytes (OLs)
mature and extend processes to contact and enwrap axons
[1,2,3,4,5,6,7,8]. Myelin formation is critical for the proper
function and maintenance of axons [9] and, on the other hand,
the survival of OLs depends on their interactions with axons [10].
Myelin loss thus results in pathological conditions, such as multiple
sclerosis in which demyelination and concurrent axonal loss lead
to significant disabilities. Thus, finding the factors that can
promote myelin formation is of major relevance for the
physiological organization and function of the CNS.
Hemopexin (Hx) is an acute phase plasma glycoprotein with
high heme binding affinity (Kd,10
29 M) [11] mainly produced
by the liver and, to a lesser extent, by several other extrahepatic
sites. In particular, Hx protein was found in neurons and
astrocytes of cerebral cortex, cerebellum, striatum and hippo-
campus [12], in ganglionic and photoreceptor cells of the retina,
in Schwann cells of the peripheral nervous system and in kidney
mesangial cells [13,14,15,16]. Moreover, by using mice bearing a
knock-in allele expressing beta-galactosidase instead of Hx, we
demonstrated that in the CNS, Hx is produced by ependymal
cells lining the ventricular system and by hippocampal neurons
[17].
Hepatocyte-derived Hx is released into the plasma where it
binds heme and delivers it back to the liver [18]. In this way, Hx
acts as a protective protein against free heme-mediated oxidative
stress, which contributes to iron homeostasis through the recycling
of heme iron [19,20]. On the other hand, extra-hepatic production
of Hx has been proposed to have a protective role following local
tissue damage [11].
Little is known about the role of Hx in the CNS, with the only
data coming from the analysis of Hx
2/2 mice. These animals are
more susceptible to ischemic stroke than wild-type controls [12].
Moreover, they have a higher number of iron-loaded OLs
compared to age-matched wild-type mice, which is not associated
to an increase in ferritin expression resulting in oxidative stress
[17]. These data suggest that OLs are particularly sensitive to the
lack of Hx and, together with the notion that iron is an essential
factor in OL biology [21], prompted us to investigate the
myelination state of Hx
2/2 mice.
We found a reduced myelination in Hx
2/2 mice compared to
age-matched wild-type controls, resulting in motor dysfunction.
Hypomyelination is due to a defective differentiation of OLs
associated to a progressive impairment of their function with
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biology, as a ‘‘differentiation factor’’ at early stages of life and as a
‘‘maintenance factor’’ for the later stages.
Materials and Methods
Animals
Hx
2/2 mice were generated in our laboratory as previously
described [22]. Hx
2/2 and wild-type mice used for experiments
were in the 129Sv genetic background and were maintained on a
standard diet. All procedures involving the use of live animals were
performed under the supervision of a licensed veterinarian,
according to guidelines specified by the Italian Ministry of Health
(DDL 116/92) and were approved by the Ethics Committee of the
Molecular Biotechnology Center (University of Torino, Italy).
Histology
Animals were anaesthetised with Avertin (2,2,2-tribromoetha-
nol; Sigma-Aldrich, Milano, Italy) at a dose of 2 mg/kg body
weight and transcardially perfused with 0.1 M phosphate-buffered
saline (PBS), pH 7.2 followed by fixative solution (4% parafor-
maldehyde in PBS). Brains were removed and post-fixed in the
same fixative for 3 h at 4uC, washed in PBS, cryoprotected by
immersion in 30% sucrose in PBS overnight, embedded and
frozen in cryostat medium (Bio-Optica, Milano, Italy). Brains were
cut in coronal 50 mm-thick, free-floating sections which were
stored in PBS at 4uC for Black-Gold analysis or collected in a
cryoprotectant solution (30% ethylene glycol and 25% glycerol in
PBS) at 220uC for immunohistochemistry.
Black-Gold myelin staining
Tissue sections were mounted onto gelatin-coated slides and air
dried at 60 uC for 30 min on a slide warmer. Slides were then
transferred to pre-warmed 0.2% Black-Gold solution dissolved in
0.9% saline vehicle, for 15 min at 60 uC. At this time, the extent of
the impregnation was monitored microscopically every 2–3 min
until complete myelin impregnation was observed, i.e. when the
finest myelinated fibers were stained. To intensify the staining,
slides were incubated in pre-warmed 0.2% potassium tetrachlor-
oaurate (III) in saline, for 15 min at 60uC. Next, slides were rinsed
for about 2 min in distilled water, fixed in a 2% sodium thiosulfate
solution for 3 min and rinsed in tap water for 15 min. Sections
were finally dehydrated and mounted with DPX (BDH Labora-
tory Supplies, Leicester, United Kingdom). Three Hx
2/2 and
three wild-type mice were used for each age-point, i.e. two, six and
twelve months.
Immunohistochemistry
Tissue sections were washed in PBS, transferred to gelatinized
slides, air dried at 37uC and analyzed with the following
antibodies: mouse monoclonal CC1 antibody (also called APC,
Adenomatus Polyposis Coli; 1:25; Calbiochem, Beeston Notting-
ham, United Kingdom), rabbit polyclonal anti-glial fibrillary acid
protein (GFAP) antibody (1:500, Dako Cytomation, Milano, Italy)
and rat monoclonal anti-CD140a (also called PDGFRa, 1:500,
BD Biosciences, Erembodegem, Belgium). Briefly, tissue sections
were rehydrated in PBS, incubated in 0.3% hydrogen peroxide in
PBS (RT) for 20 min, treated with 0.3% Triton-X-100 in Tris-
buffered saline (TBS) for 30 min and saturated with blocking
buffer (3% milk, 10% normal swine serum in TBS) for 1 h,
followed by antibody incubation at 4u C overnight. The following
biotinylated secondary antibodies were used: swine anti-rabbit
IgG, rabbit anti-rat IgG and rabbit anti-mouse IgG (DakoCyto-
mation). Immunoreactivity was enhanced with Elite ABC system
(DakoCytomation) and developed with DAB. Sections were
transferred to gelatinized slides, rinsed in PBS, dehydrated and
mounted in DPX (BDH Laboratory Supplies). To visualize mature
OLs a protocol was developed to combine CC1 and GFAP
immunohistochemistry. Sections were processed for the first
primary antibody (mouse anti-CC1) using MOM kit (Vector
Laboratories) and DAB developing method; the second primary
antibody (rabbit anti-GFAP) was processed normally as previously
described and developed with Vector SG substrate kit for
peroxidase (Vector Laboratories, DBA ITALIA, Segrate, MI,
Italy). Quantification of positive cells was performed with a
computer-microscope system equipped with the NeuroLucida
program (Microbrightfield, Inc., Williston, VT, USA). Positive
cells were counted on 50 mm-thick serial sections obtained every
0.6 mm through the corpus callosum and the cortex region. Three
Hx
2/2 and three wild-type mice were used for each age-point, i.e.
postnatal day 10 (P10) and 20 (P20).
Western blotting analysis
Freshly dissected brain cortex and basal ganglia were washed
and stored at 280 uC. Frozen samples were powdered with a
pestle in the constant presence of liquid nitrogen and dissolved in
50 mM HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid), 50 mM NaCl, 5 mM EDTA (ethylenediaminetetraacetic
acid) with protease inhibitors (aprotinin, leupeptin, pepstatin;
Sigma-Aldrich). Fifty mg of total protein extracts were separated on
SDS-PAGE and analysed by Western blotting according to
standard protocol using a rabbit polyclonal anti-Myelin Basic
Protein (MBP) antibody (Immunological sciences, Rome, Italy)
and a rabbit polyclonal anti-Actin antibody (Santa Cruz
Biotechnology, Heidelberg, Germany). The intensities of bands
were quantified with the Bio-Rad Gel Doc system using Quantity
One software. Three Hx
-/- and three wild-type mice were used for
each age-point, i.e. two and twelve months.
Electron Microscopy (EM)
Twelve month-old Hx
2/2 and wild-type mice were killed with
an overdose of anesthetic and perfused transcardially with a
washing solution (phosphate buffer – PB – 0.12 M, pH 7.4)
followed by the fixative (4% paraformaldehyde, 2% glutaralde-
hyde in 0.12 M PB). Brains were removed, dissected, and the
corpus callosum region post-fixed in the same fixative for 2 h
before transferring to 0.12 M PB. Specimens were immersed in
1% OsO4 in cacodylate buffer, dehydrated in ethanol and
embedded in epoxy resin. Ultrathin sections (60 nm) were
obtained with an ultra microtome Ultracut E Reichert-Jung and
then were stained with uranyl acetate and lead citrate for
examination with a transmission electron microscope CM 10
Philips (FEI, Eindhoven, Netherlands). Randomly selected EM
images were analyzed using the Image J 1.37v software (National
Institute of Health, Bethesda, MD, USA). Five animals of each
genotype were used.
Behavioural testing: Rotarod
The motor coordination was examined by using an accelerating
rotarod test (model 760; Ugo Basile, Varese, Italy). The rotating
rod underwent linear acceleration from 4 to 32 rpm over the first
5 min of the trial. The rotarod test was performed by placing a
mouse on a rotating treadmill drum (3 cm diameter) and
measuring the time period for which each animal was able to
maintain its balance on the treadmill. After two min training runs,
the mice underwent testing three times for a maximum of 300 sec,
and the mean latency to fall off the treadmill was recorded. Mice
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month. Sixteen animals of each genotype were used.
Isolation and culture of oligodendrocyte precursor cells
Primary OL cultures were prepared from forebrains of 3 to 4-
day-old rat pups using a differential detachment method. Briefly,
forebrains free of meninges were digested with Hanks Balanced
Salt Solution (HBSS) containing 0.01% trypsin, and mechanically
dissociated in DMEM 20S (Dulbecco’s modified Eagles medium
High Glucose (DMEM) with 20% fetal bovine serum, 2 mM L-
glutamine, and 100 U/mL penicillin, 100 mg/mL streptomycin,
2.5 mg/mL Fungizone e 1 mM Na-piruvate). Dissociated cells
were plated onto poly-L-lysine coated 75 cm
2 flasks (1 cerebrum
per flask) and maintained 9 days at 37uC in a humid atmosphere
of 5% CO2 and 95% air; medium was changed completely every
two days. Then, oligodendrocyte precursor cells (OPCs) were
isolated from the mixed glial cells by the method of McCarthy and
DeVellis [23]. Briefly, following 1 h pre-shake to remove
microglia, flasks were shaken overnight at 200 rpm to separate
OPCs from the astrocyte layer. Cell suspensions were then plated
onto uncoated Petri dishes for 1 h to further remove residual
contaminating microglia/astrocytes. Resulting OPCs were plated
onto poly-D,L-ornithine-coated 24-well titer at a density of 30000
cells/well, and maintained in Neurobasal medium supplemented
with B27 (NBB27), 10 ng/ml PDGF and 10 ng/ml bFGF for 4
days to stimulate the propagation of OPCs. At this time cultures
were assessed to be greater than 95% OPCs by immunocyto-
chemistry, using antibodies specific to astrocytes and microglial
cells. The medium was then changed with NBB27 without growth
factors and cells were treated with Hx purified from human serum
(100 nmol/L; Athens Research & Technology, Athens, GA, USA),
or with heme–Hx complex (100 nmol/L; heme was purchased by
Frontier Scientific Europe, Carnforth, Lancashire, UK) for 2 days
and then analyzed by immunofluorescence to evaluate OPC
differentiation. Both Hx and heme were negative for endotoxin
contamination.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde in PBS, quenched
with50 mMammonium chloride,permeabilized with0.1%Triton-
X-100 in PBS for 30 min, saturated with blocking buffer (3%
normal bovine serum in PBS) for 1 h and incubated for 2 h with the
following primary antibodies: rabbit polyclonal anti-glial fibrillary
acid protein (GFAP) antibody (1:500, Dako Cytomation, Milano,
Italy), rabbit polyclonal anti-IBA1 (1:1000, Wako Chemicals
GmbH, Neuss, Germany), rat monoclonal anti-CD140a (1:500,
BD Biosciences), rabbit polyclonal anti-PDGFRa (1:500, Abcam,
Cambridge, UK), mouse monoclonal anti-CNPase (1:200, Milli-
pore S.p.A., Milan, Italy) rat monoclonal anti-MBP (1:100, Abcam,
Cambridge, UK). Cells were then incubated for 1 h with the
appropriate Alexa Fluor-conjugated secondary antibodies (Invitro-
gen, Carlsbad, CA, USA) and nuclei were stained using DAPI.
Cells were counted and categorized into four stages of OL
differentiation accordingtotwo criteria:i)morphology:stage I:OPC
(mono/bipolar), stage II: pre-OL (multipolar, primary branched);
stage III: immature OL (multipolar, secondary branched); stage IV:
mature OL (secondary branched cells with membranous processes)
[24]; ii)marker expression, stage I and II: PDGFRa positive,
CNPase negative, stage III: PDGFRa negative, CNPase positive,
stage IV: PDGFRa negative, CNPase and MBP positive.
Statistical Analysis
Difference among groups in terms of MBP density and OL
count were analyzed by Student’s t-test, a P-value less than 0.05
was considered significant. For comparison between the histogram
distributions, the Chi-square goodness-of-fit test was used, the level
of significance adopted was P,0.05. The plot of g-ratio was
analyzed with Wilcoxon test for nonparametric data. For rotarod
analysis, the time to fall in the rotating rod test was analyzed by
two-way analysis of variance (ANOVA). In vitro experiments were
analyzed by paired t-test.
Results
Hx
-/- mice show altered myelin basic protein expression
in brain
We have already demonstrated that OLs are more susceptible
than other cell types to lack of Hx as they accumulate heme-
derived iron [17]. As iron availability may affect the state of
myelination [21], we posed the question whether iron load in OLs
of Hx
2/2 mice impairs their ability to form myelin and therefore
analyzed the expression of MBP, one of the major myelin proteins
[25], in two distinct regions of Hx
2/2 mouse brains: cerebral
cortex (motor and somatosensory areas) and basal ganglia, at two
and twelve months of age. Immunoblot analysis on samples from
two month-old mice showed a slight, but significant reduction in
MBP content in the cortex of Hx
2/2 mice compared to wild-type
animals. In twelve month-old mice the reduction of MBP in Hx
2/2
mice was more evident in both cerebral cortex and basal ganglia
(Figure 1). The anti-MBP antibody revealed signals for all four
bands of MBP, representing MBP splice variants and, in Hx
2/2
mice, reduced expression affected all isoforms. Particularly, the less
abundant 21.5 KDa isoform showed a reduction of about 60% in
the cortex of 2 month-old mice, and of 40–50% in the cortex and
basal ganglia of 12 month-old animals, whereas the other isoforms,
18.5, 17 and 14 KDa, showed a similar reduction of about 30–40%
both in the cortex at 2 months and in the cortex and basal ganglia at
12 months of age (not shown).
Hx
2/2 mice show impaired myelination
We investigated the structure of myelinated fibers in the
cerebral cortex of 2, 6 and 12 month-old mice using the Black-
Gold stain, which specifically labels myelin. Fiber systems such as
the corpus callosum and the internal capsule are labeled in red,
whereas individual axons appear dark black. Differences in myelin
structure were already evident at two months of age, worsened at
six months and persisted in 12 month-old mice (Figure 2). As
shown in Figure 2A, brain sections of 12 month-old wild-type mice
showed a diffuse and regular staining in all layers of the cortex,
with a dense network of fibers, mostly horizontally oriented, in
infragranular layers: from this network, dark black, thick axons
originate, with a radial orientation, which ramify in the
supragranular layers in a dense network of thin collaterals. In
Hx
2/2 brain sections, the density of the staining was clearly lower
than in wild-type brain sections at low magnification. High-
magnification images showed that in the supragranular cortical
layers of the cortex, in particular layers I and II, in Hx
2/2 mice,
myelinated axons were less dense and thinner than in wild-type
animals. This finding was corroborated by the observation of a
reduced thickness of the axons radiating from infra- to
supragranular layers. Affected areas include motor and somato-
sensory cortex. We quantified Black-Gold staining by densitometry
in four consecutive sections in the motor cortical area: intensity of
staining, indicative of the density of myelinated fibers, increased
from 2 to 6 months of age and remained high at 12 months in both
wild-type and Hx
2/2 mice. In the latter we observed a 40–50%
reduction in the density of myelinated fibers at all ages compared
to wild-type controls (Figure 2B).
Hemopexin in Oligodendrocyte Differentiation
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2/2 mice display altered myelin structure
To determine whether myelin structure as well as myelin density
were compromised in Hx
2/2 mice, we analyzed sagittal sections
of corpus callosum from twelve month-old wild-type and Hx
2/2
mice by EM. We did not find differences in the number of
unmyelinated/myelinated fibers in the corpus callosum between
Hx
2/2 and wild-type mice (Table 1). Nevertheless, electron
micrographs showed that the myelinated axons in Hx
2/2 mice
were severely hypomyelinated (Figure 3A, top). Higher magnifi-
cation (Figure 3A, bottom) revealed that myelinated axons in
Hx
2/2 mice showed ultrastructural abnormalities. Indeed, unlike
wild-type mice, Hx
2/2 mice were characterized by the presence of
numerous enlarged fibers with pale-stained cytoplasm in which
neurofilaments were sparsely organized. Frequency distribution of
myelin thickness (Figure 3B) revealed a shift towards lower values
(Chi-square analysis, P,0.0001) in Hx
2/2 mice fibers compared
with wild-type mice, confirmed by an increase in the ratio of axon
size to fiber diameter (g-ratio) in Hx
2/2 mice compared with wild-
type mice (Wilcoxon test, P,0.001) (Figure 3C). In addition, the g-
ratio analysis revealed that hypomyelination affected axons of all
size. Moreover, some myelinated fibers in Hx
2/2 mice showed
oligodendroglial cytoplasm between the compacted lamellas as
well as between axon and the internal myelin layer. Interestingly,
frequency distribution of axonal diameter (Figure 3D) showed a
shift towards larger fibers in Hx
2/2 mice compared with wild-type
mice (Chi-square test, P,0.0001).
Hx
2/2 mice exhibit motor dysfunction
To assess whether hypomyelination in motor cortex of Hx
2/2
mice had an effect on motor function, we tested motor
coordination ability in these animals from 2 to 12 months of
age, using the Rotarod test (Figure 4). The performance of wild-
type mice was unchanged with increasing age, whereas in the
Hx
2/2 mice motor coordination deteriorated progressively by 4
months of age. The reduction in motor function in Hx
2/2 mice
became significant by seven months of age (mean score reduction
of 23%) and worsened gradually until twelve months of age (mean
score reduction of 34%).
Hx
2/2 mice have reduced number of mature OLs
The deficit in myelin content of Hx
2/2 mice might be the result
of a reduction in the number of OLs or a reduction in the amount
of myelin elaborated by each individual oligodendrocyte. To
investigate this issue, we analyzed mature OL and OPC numbers
in selected CNS areas, the cerebral somatosensory cortex and the
corpus callosum, of Hx
2/2 and control mice at P10 and P20.
OPCs were identified as PDGFRa-labeled cells, and mature OLs
as CC1-positive and GFAP-negative cells. At P10, we observed a
significant 40% and 30% reduction in the number of mature OLs
in Hx
2/2 mice compared to wild-type animals in the cerebral
cortex and corpus callosum, respectively, whereas OPC numbers
were similar. The difference in the number of mature OLs
persisted at P20 with a reduction of 40% and 15% in the cerebral
cortex and corpus callosum, respectively (Figure 5A). Maps of
positive cells in stained sections confirmed that Hx
2/2 mice were
characterized by fewer mature OLs in the corpus callosum and
cerebral cortex compared to wild-type mice. In the somatosensory
cortex, the reduction in the number of mature OLs mainly
affected the supragranular layers (Figure 5B).
Because the density of OPCs is similar between wild-type and
Hx
2/2 mice, these data suggest that Hx is involved in regulating
the differentiation and/or the survival of OLs.
Hx promotes OPC differentiation in vitro
As described in the previous paragraph Hx
2/2 mice showed a
deficit in mature OLs whereas OPC numbers were normal. Hx
Figure 1. Reduction of MBP protein production in Hx
2/2 brain. A) Western blot analysis of MBP expression in brain extracts of wild-type and
Hx
2/2 mice. Cerebral cortex and basal ganglia region lysates were analyzed at two and twelve months of age. Representative experiments are shown.
B) Band intensities were measured by densitometry and normalized to actin expression (AU: Arbitrary Unit). The overall MBP production was
obtained by summing the relative intensities of the four isoforms recognized by the antibody (indicated by arrows in scanned gels). Densitometry
data represent mean 6 SEM; n=3 for each genotype. * = P,0.05. Results shown are representative of three independent experiments.
doi:10.1371/journal.pone.0020173.g001
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increases until adulthood and mainly occurs in ependymal cells
lining the subventricular zone where OPCs arise (data not shown).
These issues suggest that Hx may affect OPC differentiation. To
test this hypothesis we analyzed the effect of Hx on OPC cultures:
differentiation of OPCs was assessed on the basis of both
morphological and immunological changes (Figure 6A).
After 48 h in the differentiation medium, in untreated OPC
cultures we observed approximately an equal number of immature
(PDGFa-positive, stage I–II) and more differentiated cells
(PDGFa-negative, CNPase-positive, stage III–IV). In contrast,
Hx treatment markedly accelerated the differentiation process
resulting in a significant reduction of the number of immature cells
in favour of an increase of mature OLs (30% of cells at stages I–II
and 70% at stages III–IV) (Figure 6B). Moreover, Hx treatment
produced an increase in the number of terminally differentiated
myelin-forming OLs characterized by MBP expression (not
shown). In agreement with the immunological changes, the
presence of Hx in the differentiation medium produced an
increase in the complexity of cell processes. In fact, accordingly to
immunofluorescence data, in Hx-treated cultures we observed less
cells with bipolar morphology (stage I) or primary branches (stage
II) and a higher number of cells with secondary branches or
membranous processes (stage III–IV).
Conversely, heme-bound Hx was not able to produce significant
modifications in the morphology or in the immunological
properties of OPCs (Figure 6B).
Taken together these data indicate that Hx has a pro-OL
differentiation activity that is inhibited by interaction with heme.
Discussion
In this work we have highlighted for the first time a role for Hx
in OL development by demonstrating that the brains of Hx
2/2
mice are hypomyelinated, likely due to a result of a defective OPC
maturation. Moreover, we have shown that Hx is able to promote
OL differentiation in culture.
Hypomyelination, demonstrated by reduced MBP expression
and Black-Gold staining and by ultrastructural abnormalities, was
already evident in 2 month-old Hx
2/2 mice and worsened with
aging. We reported that in Hx
2/2 mice the less abundant MBP
isoform of 21.5 KDa was more severely reduced than the other
three. Interestingly, an isoform-specific reduction of MBP
expression has already been observed in other knock-out models
and has been correlated to functional differences among the
isoforms [26,27,28]. Thus, it is possible to speculate that the lack of
Hx affects the expression of specific populations of myelinating
cells.
Our in vitro data showed that Hx treatment increased the
number of cells with more mature morphologies (immature and
mature OL) and reduced the number of cells displaying the
immature morphology (OPC and preOL). This might occur
through the activation of specific signalling pathways governing
cell differentiation. Others have already reported that inhibition
of the MAPK/ERK pathway generated an opposite result to
what we obtained with Hx, i.e. a significant increase and
decrease in the number of immature and mature cells
respectively, associated to the appearance of a novel subpopu-
lation of OL, positive for CNPase and MBP but without cellular
processes, indicating that MAPK/ERK signalling is needed for
oligodendroglial branching [29]. We did not observe this
subpopulation in our cultures but only an increase in the
number of more mature cells, that is, cells with secondary
branches. This might indicate that Hx is able to potentiate the
MAPK/ERK pathway, directly through the binding to a specific
receptor or indirectly by modulating the activity of another
ligand and/or receptor.
The phenotype of Hx
2/2 mice shows striking similarities with
that of mice lacking matrix metalloprotease (MMP)9 and/or
Figure 2. The cortex of Hx
2/2 mice is hypomyelinated.
A) Coronal sections of a wild-type and a Hx
2/2 mouse at twelve
months of age stained with Black-Gold reaction to detect myelinated
fibers. Hx
2/2 mouse shows reduced myelination in cerebral cortex
compared to wild-type (a, b) and the hypomyelination mainly affects
the supragranular layers in motor and somatosensory cortex (arrows in
c, d). Higher magnification shows that in layer I of Hx
2/2 mouse the
staining is very weak compared to wild-type (e, f). Bar (c, d) =500 mm;
Bar (e, f) =100 mm. B) Quantification of fiber density in motor cortical
area, assessed at 2, 6 and 12 months of age, shows a severe reduction in
Hx
2/2 mice. Data represent mean 6 SEM, n=3 mice for each genotype.
*= P ,0.05, *** =P,0.001.
doi:10.1371/journal.pone.0020173.g002
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2/2
mice at twelve month of age. A) Electron micrographs show that in Hx
2/2 mice the axons are hypomyelinated and the number of small myelinated
axons is reduced in comparison to wild-types. Bar =1 mm. B) The distribution of myelin thickness in wild-type and Hx
2/2 mice fibers demonstrated that
myelinsheathwasthickerinHx
2/2fibers.P,0.0001.C)g-ratioscatterdiagraminwild-typeandHx
2/2micefibers.Elevatedgratiovalueswereobserved
for all axons in Hx
2/2 mice, indicating that impaired myelination affected axon of all sizes. P,0.001. D)The distribution of axonal size in wild-type and
Hx
2/2 mice fibers showed that Hx
2/2 mice had bigger axons compared to controls. P,0.0001. n=5 mice for each genotype.
doi:10.1371/journal.pone.0020173.g003
Table 1. Axon density in corpus callosum of wild-type and Hx
2/2 mice.
Mice
Average No. of myelinated
axons/field
Average No. of unmyelinated
axons/field Average No. of axons/field
Percentage unmyelinated
axons
Wild-type 36.0664.15 25.0064.11 61.0666.92 40.95
Hx
2/2 33.9062.91 25.5065.02 59.4065.50 42.93
The number of myelinated (axons containing compact myelin) and unmyelinated axons were counted in a 30 mm
2 area from electron micrographs of corpus callosum
sections. There were no changes in axon density between wild-type and Hx
2/2 mice. Values are the average number of axons per field 6 SD. Wild-type, n =3; Hx
2/2,
n= 3 .
doi:10.1371/journal.pone.0020173.t001
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development correlated to a decrease in mature OLs in spite of a
normal precursor cell number [30]. This has been imputed to the
ability of MMP9 and MMP12 to degrade specific substrates that
inhibit OL differentiation, one of which being Insulin Growth
Factor binding protein 6 (IGFBP-6) [30]. Interestingly, the kinetics
of Hx expression in the CNS is very similar to that of MMP9, with
both proteins starting to be produced by P7 and increasing steadily
from P14 to P28, a temporal pattern that coincides with
developmental myelination [31]. In addition, both Hx and MMPs
are cleared from the extracellular environment by low-density
lipoprotein receptor-related protein-1 (LRP-1) [32,33], a scaven-
ger receptor expressed in CNS by epithelial cells of choroid plexi,
endothelial cells of microvessels, neurons, perivascular astrocytes,
and microglial cells [34,35,36].
Furthermore, Hx and most MMPs share the so called
‘‘hemopexin domain’’, a structural motif that is involved in
MMPs’ activation/inhibition, binding and cleavage of different
substrates, localization and degradation [37]. Thus, we may
speculate that during developmental myelination Hx modulates
the activity of some proteases of the extracellular environment or
of the cell membrane crucial for OL differentiation. In particular,
our in vitro data showing that Hx is able to promote OL
differentiation in serum-free media on minimally coated sub-
strates, suggest that Hx activity may modulate some autocrine
circuit essential for differentiation.
Figure 4. Motor dysfunction in Hx
2/2 mice. Accelerated Rotarod
tests were performed every fifteen days from two to twelve months of
age. The mean time score in which the mice walked in synchrony with
the rod was recorded. Each test consisted of three consecutive trials.
Hx
2/2 mice showed significant motor impairment starting from four
months of age and increasing with age. Data represent mean 6 SEM,
n=16 mice for each genotype. *= P,0.05, ** =P,0.01, *** =P,0.001.
doi:10.1371/journal.pone.0020173.g004
Figure 5. Impaired OL development in Hx
2/2 mice. Brain sections of wild-type and Hx
2/2 mice were immunoreacted to discriminate between
OPCs and mature OLs and OPCs and OLs counted as reported in Materials and Methods. A) Quantification of PDGFRa-positive cells demonstrated
similar numbers of OPCs in both cerebral cortex and corpus callosum in Hx
2/2 and wild-type mice at P10. On the contrary, the number of CC1-
positive, GFAP-negative mature OLs in Hx
2/2 mice was strongly reduced compared to wild-type animals at P10 and P20. Data represent mean 6
SEM, n=3 mice for each genotype. ** =P,0.01, *** =P,0.001. B) Maps, obtained with Neurolucida/Neuroexplorer, of brain sections of PDGFRa-
(left) and CC1- (right) positive cells, respectively, in Hx
2/2 and wild-type mice at P10. Red = OPCs, blue = mature OLs. Note the reduced number of
mature OLs in the supragranular layer of cortex in Hx
2/2 mice. C) Representative pictures of CC1/GFAP double staining for CC1 (brown) and GFAP
(grey) in brain sections of a wild-type and a Hx
2/2 mouse. The latter shows a strong reduction in the number of CC1 positive cells in the cortex
(arrows) and in corpus callosum, CC, (arrow-heads) compared to wild-type animal. Bar =50 mm.
doi:10.1371/journal.pone.0020173.g005
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plasma and the recombinant protein show protease activity
[38,39,40,41], leaves open the possibility that Hx per se may
degrade some critical substrate for OL differentiation.
The effect of Hx on OL differentiation in vitro is inhibited by
binding of Hx to its ligand heme suggesting that the different Hx
functions of promoting OL differentiation and scavenging free
heme are mutually exclusive. It is possible that the binding of Hx
with heme may mask some critical domain for OL differentiation.
It is important to note that the concentration of Hx in the
differentiation medium used in this study is very low (0.1 mM),
comparable to that of MMPs analyzed in other works and in
agreement with the amount of protein expected in brain
parenchyma, whereas the heme scavenging function, mediated
by plasma Hx, occurs at very high protein concentration (10–
20 mM).
Interestingly, deficient myelination in MMP9
2/2 and/or
MMP12
2/2 mice occurred transiently from P7 to P14 [30],
whereas in Hx
2/2 mice it worsened with age as we observed a
reduced number of mature OL at P10 and P20 that correlated
with reduced MBP expression at 2 months of age and impaired
myelin deposition. The deficit in myelin deposition was already
evident at 2 months of age and worsened from 2 to 6 months
suggesting that Hx is not only involved in the early stages of OL
differentiation, but also at later stages of myelination and in OL
maintenance. Finally, the myelin deficit results in the impairment
of motor function which was consistently evident by 4 months and
progressively declined. The role of Hx in OL maintenance is likely
due to its ability in preventing heme-mediated oxidative injury
and/or in modulating iron accumulation in OLs [17]. Indeed, we
have previously shown that adult Hx
2/2 mice have a significant
higher number of iron-overloaded OLs compared to wild-type
animals and this results in the induction of markers of oxidative
stress, the latter being likely responsible for the impairment of OLs
function with age.
On the other hand, due to the crucial role of iron in myelination
[21], it should also be taken into account the possibility that Hx
may affect myelination by controlling heme-iron delivery to OLs.
However free heme is a dispensable source of iron in physiologic
condition becoming heme-iron highly available only under
pathologic conditions associated to hemolysis. OLs obtain much
of their iron in the form of inorganic ion via receptor-mediated
uptake of H-ferritin [21]. Even though we have previously
reported that both H- and L-ferritin levels were reduced in the
brain of Hx2/2 mice [17], that reduction was due to a decreased
number of ferritin-positive cells limited to the cortical regions that
now can be imputed to the deficit in OL cell number. Being iron
available to a reduced number of cells, it likely accumulates in
excess thus rendering OL more susceptible to oxidative damage.
Putting together this and our previous work, we conclude that
the reduced number of OLs that reach maturity in Hx
2/2 brains,
due to the lack of a differentiation factor, are further exposed to a
higher amount of iron which in turn worsen their viability and
functional activity. In addition, Hx might limit oxidative damage
by scavenging free heme eventually released by cerebral tissue, the
latter function becoming much more important in hemolysis-
associated pathologic conditions. Consistently, it has recently been
reported that Hx
2/2 mice are more susceptible to ischemic stroke
and intracerebral hemorrhage [12,42]. Moreover, Hx has been
found to be strongly increased in the cerebrospinal fluid of patients
suffering from Alzheimer’s disease [43], further suggesting a
potential protective role.
At the ultrastructural level, we found that in Hx
2/2 mice there
was a significant increase in axons bearing a thinner myelin sheath
than normal in absence of differences in the number of
unmyelinated/myelinated fibers. This is in concordance with the
reduced number of OLs expected to myelinate a normal number
of axons. The abnormalities in myelin deposition observed in
Hx
2/2 mice are likely expression of a disturbance in myelin
compaction that again might be imputed to an effect of Hx on
specific subpopulations of myelinating cells [44,45]. Hx
2/2 axons
showed enlarged diameter and disorganized neurofilaments,
typical of dystrophic axons: these alterations are likely to be the
morphological substrates for motor dysfunction, since the
organization of neurofilaments is fundamental for maintaining
the three-dimensional array of axoplasm and the conduction
properties of the axonal fiber [46].
We focused our functional analysis on motor behaviour, but our
data indicate that the myelin deficit occurs throughout the cerebral
cortex of Hx
2/2 mice, thus suggesting that not only motor
Figure 6. Hx promotes OL differentiation. OPCs were grown with
or without Hx and the differentiation process was analyzed.
A) Representative images showing the different developmental stages
taken into consideration: stage I, OPCs (bipolar); stage II: pre-OL
(primary branched); stage III: immature OL (secondary branched); stage
IV: mature OL (secondary branched cells with membranous processes).
Cells at stage I and II are PDGFRa positive, CNPase negative, cells at
stage III are PDGFRa negative, CNPase positive and cells at stage IV are
PDGFRa negative, CNPase and MBP positive. B) Kinetics of OL
differentiation. Cells were cultured for 48 h in the absence (NT) or
presence of Hx (Hx) or heme-Hx complex (Hx-heme), and the number of
cells at each differentiation stage was counted as reported in Materials
and Methods. Cells were scored by morphology and immunoreactivity
to PDGFa and CNPase as shown in (A). Hx treatment accelerated the
differentiation process whereas the heme-Hx complex was ineffective.
*=P ,0.05. Results shown are representative of three independent
experiments.
doi:10.1371/journal.pone.0020173.g006
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by the lack of Hx. Moreover, the results of this work are in line
with those previously reported on the expression of Hx after
peripheral nerve injury [47,48,49]. In fact, Madore and co-
workers demonstrated that, after sciatic nerve crush, Hx mRNA is
expressed by Schwann cells, fibroblasts and invading blood
macrophages: the protein accumulates in the extracellular matrix
and its expression progressively declines during nerve regenera-
tion, thus suggesting a role in nerve repair. We may now speculate
that this role resides in the ability of Hx to also promote
myelination in the PNS.
In conclusion, we have identified a novel factor important for
developmental myelination. Our work sheds light on future
strategies to repair myelin in the adult CNS after a demyelinating
insult.
Acknowledgments
We thank Marta Fumagalli (Department of Pharmacological Sciences,
University of Milan, Milan, Italy) for the technical assistance on OPC
culture and Flavia Favilla for help with some experiments. We are grateful
to Radhika Srinivasan for editing of the manuscript.
Author Contributions
Conceived and designed the experiments: NM E. Tolosano. Performed the
experiments: NM FTB E. Tonoli. Analyzed the data: NM FTB E. Tonoli
LS AV FA E. Tolosano. Contributed reagents/materials/analysis tools:
PM VRM GC. Wrote the paper: NM AV FA E. Tolosano.
References
1. Bauer NG, ffrench-Constant C (2009) Physical forces in myelination and repair:
a question of balance? J Biol 8: 78.
2. Bauer NG, Richter-Landsberg C, Ffrench-Constant C (2009) Role of the
oligodendroglial cytoskeleton in differentiation and myelination. Glia 57:
1691–1705.
3. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the
mammalian central nervous system. Physiol Rev 81: 871–927.
4. Dangata YY, Kaufman MH (1997) Myelinogenesis in the optic nerve of (C57BL
x CBA) F1 hybrid mice: a morphometric analysis. Eur J Morphol 35: 3–17.
5. Dyer CA (2002) The structure and function of myelin: from inert membrane to
perfusion pump. Neurochem Res 27: 1279–1292.
6. Hardy R, Reynolds R (1991) Proliferation and differentiation potential of rat
forebrain oligodendroglial progenitors both in vitro and in vivo. Development
111: 1061–1080.
7. Hardy R, Reynolds R (1993) Neuron-oligodendroglial interactions during
central nervous system development. J Neurosci Res 36: 121–126.
8. Skoff RP (1976) Myelin deficit in the Jimpy mouse may be due to cellular
abnormalities in astroglia. Nature 264: 560–562.
9. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al. (2003)
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and
myelination. Nat Genet 33: 366–374.
10. Trapp BD, Nishiyama A, Cheng D, Macklin W (1997) Differentiation and death
of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:
459–468.
11. Tolosano E, Fagoonee S, Morello N, Vinchi F, Fiorito V (2010) Heme
scavenging and the other facets of hemopexin. Antioxid Redox Signal 12:
305–320.
12. Li RC, Saleem S, Zhen G, Cao W, Zhuang H, et al. (2009) Heme-hemopexin
complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow
Metab 29: 953–964.
13. Hunt RC, Hunt DM, Gaur N, Smith A (1996) Hemopexin in the human retina:
protection of the retina against heme-mediated toxicity. J Cell Physiol 168:
71–80.
14. Kapojos JJ, van den Berg A, van Goor H, te Loo MW, Poelstra K, et al. (2003)
Production of hemopexin by TNF-alpha stimulated human mesangial cells.
Kidney Int 63: 1681–1686.
15. Liem HH, Tavassoli M, Muller-Eberhard U (1975) Cellular and subcellular
localization of heme and hemopexin in the rabbit. Acta Haematol 53: 219–225.
16. Swerts JP, Soula C, Sagot Y, Guinaudy MJ, Guillemot JC, et al. (1992)
Hemopexin is synthesized in peripheral nerves but not in central nervous system
and accumulates after axotomy. J Biol Chem 267: 10596–10600.
17. Morello N, Tonoli E, Logrand F, Fiorito V, Fagoonee S, et al. (2009)
Haemopexin affects iron distribution and ferritin expression in mouse brain.
J Cell Mol Med 13: 4192–4204.
18. Tolosano E, Altruda F (2002) Hemopexin: structure, function, and regulation.
DNA Cell Biol 21: 297–306.
19. Gutteridge JM, Smith A (1988) Antioxidant protection by haemopexin of haem-
stimulated lipid peroxidation. Biochem J 256: 861–865.
20. Vinchi F, Gastaldi S, Silengo L, Altruda F, Tolosano E (2008) Hemopexin
prevents endothelial damage and liver congestion in a mouse model of heme
overload. Am J Pathol 173: 289–299.
21. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009)
Oligodendrocytes and myelination: the role of iron. Glia 57: 467–478.
22. Tolosano E, Hirsch E, Patrucco E, Camaschella C, Navone R, et al. (1999)
Defective recovery and severe renal damage after acute hemolysis in hemopexin-
deficient mice. Blood 94: 3906–3914.
23. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and
oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890–902.
24. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, et al.
(2001) p21cip1 is required for the differentiation of oligodendrocytes
independently of cell cycle withdrawal. EMBO Rep 2: 27–34.
25. Lees MB, Samiullah M, Laursen RA (1984) Structural analogies between myelin
basic protein and proteolipid. Prog Clin Biol Res 146: 257–264.
26. Li Z, Zhang Y, Li D, Feng Y (2000) Destabilization and mislocalization of
myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-
binding proteins. J Neurosci 20: 4944–4953.
27. Lu Z, Ku L, Chen Y, Feng Y (2005) Developmental abnormalities of myelin
basic protein expression in fyn knock-out brain reveal a role of Fyn in
posttranscriptional regulation. J Biol Chem 280: 389–395.
28. Macklin WB, Gardinier MV, Obeso ZO, King KD, Wight PA (1991) Mutations
in the myelin proteolipid protein gene alter oligodendrocyte gene expression in
jimpy and jimpymsd mice. J Neurochem 56: 163–171.
29. Younes-Rapozo V, Felgueiras LO, Viana NL, Fierro IM, Barja-Fidalgo C, et al.
(2009) A role for the MAPK/ERK pathway in oligodendroglial differentiation
in vitro: stage specific effects on cell branching. Int J Dev Neurosci 27: 757–
768.
30. Larsen PH, DaSilva AG, Conant K, Yong VW (2006) Myelin formation during
development of the CNS is delayed in matrix metalloproteinase-9 and -12 null
mice. J Neurosci 26: 2207–2214.
31. Uhm JH, Dooley NP, Oh LY, Yong VW (1998) Oligodendrocytes utilize a
matrix metalloproteinase, MMP-9, to extend processes along an astrocyte
extracellular matrix. Glia 22: 53–63.
32. Dedieu S, Langlois B (2008) LRP-1: a new modulator of cytoskeleton dynamics
and adhesive complex turnover in cancer cells. Cell Adh Migr 2: 77–80.
33. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, et al. (2005)
Identification of the receptor scavenging hemopexin-heme complexes. Blood
106: 2572–2579.
34. Donahue JE, Flaherty SL, Johanson CE, Duncan JA, 3rd, Silverberg GD, et al.
(2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease. Acta
Neuropathol 112: 405–415.
35. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, et al. (2000) Clearance
of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related
protein-1 at the blood-brain barrier. J Clin Invest 106: 1489–1499.
36. Zhang C, An J, Strickland DK, Yepes M (2009) The low-density lipoprotein
receptor-related protein 1 mediates tissue-type plasminogen activator-induced
microglial activation in the ischemic brain. Am J Pathol 174: 586–594.
37. Piccard H, Van den Steen PE, Opdenakker G (2007) Hemopexin domains as
multifunctional liganding modules in matrix metalloproteinases and other
proteins. J Leukoc Biol 81: 870–892.
38. Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, et al. (2005)
Protease activity of plasma hemopexin. Kidney Int 68: 603–610.
39. Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, et al. (2005) Altered
activity of plasma hemopexin in patients with minimal change disease in relapse.
Pediatr Nephrol 20: 1410–1415.
40. Cheung PK, Klok PA, Baller JF, Bakker WW (2000) Induction of experimental
proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int
57: 1512–1520.
41. Spiller F, Costa C, Souto FO, Vinchi F, Mestriner FL, et al. (2011) Inhibition of
neutrophil migration by hemopexin leads to increased mortality due to sepsis in
mice. Am J Respir Crit Care Med 183: 922–931.
42. Chen L, Zhang X, Chen-Roetling J, Regan RF (2010) Increased striatal injury
and behavioral deficits after intracerebral hemorrhage in hemopexin knockout
mice. J Neurosurg.
43. Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, et al. (2009) Proteomics-
derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease.
Biomarkers 14: 493–501.
44. Dupree JL, Coetzee T, Suzuki K, Popko B (1998) Myelin abnormalities in mice
deficient in galactocerebroside and sulfatide. J Neurocytol 27: 649–659.
45. Ferreira AA, Nazario JC, Pereira MJ, Azevedo NL, Barradas PC (2004) Effects
of experimental hypothyroidism on myelin sheath structural organization.
J Neurocytol 33: 225–231.
Hemopexin in Oligodendrocyte Differentiation
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e2017346. Zhu Q, Couillard-Despres S, Julien JP (1997) Delayed maturation of
regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol
148: 299–316.
47. Camborieux L, Bertrand N, Swerts JP (1998) Changes in expression and
localization of hemopexin and its transcripts in injured nervous system: a
comparison of central and peripheral tissues. Neuroscience 82: 1039–1052.
48. Madore N, Camborieux L, Bertrand N, Swerts JP (1999) Regulation of
hemopexin synthesis in degenerating and regenerating rat sciatic nerve.
J Neurochem 72: 708–715.
49. Madore N, Sagot Y, Guinaudy MJ, Cochard P, Swerts JP (1994) Long-lasting
accumulation of hemopexin in permanently transected peripheral nerves and its
down-regulation during regeneration. J Neurosci Res 39: 186–194.
Hemopexin in Oligodendrocyte Differentiation
PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e20173